Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8100808)

  • 1. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
    de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
    Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
    Hayashi H; Ooi A; Nakanishi I
    Jpn J Clin Oncol; 1990 Dec; 20(4):339-48. PubMed ID: 1704442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin-A expression in gastric and colon cancer tissues.
    Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
    Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach.
    Otsuka T; Tsukamoto T; Mizoshita T; Inada K; Takenaka Y; Kato S; Yamamura Y; Miki K; Tatematsu M
    Pathol Int; 2005 Apr; 55(4):170-9. PubMed ID: 15826243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.
    Ooi A; Mai M; Ogino T; Ueda H; Kitamura T; Takahashi Y; Kawahara E; Nakanishi I
    Cancer; 1988 Sep; 62(6):1096-104. PubMed ID: 3044573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas.
    Atasoy P; Bozdoğan O; Oztürk S; Ensari A
    Tumori; 2004; 90(2):233-8. PubMed ID: 15237588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
    Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
    Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
    Ferrero S; Buffa R; Pruneri G; Siccardi AG; Pelagi M; Lee AK; Coggi G; Bosari S
    Virchows Arch; 1995; 426(6):587-92. PubMed ID: 7655739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine cells in colorectal carcinomas. Immunohistochemical study.
    Swatek J; Chibowski D
    Pol J Pathol; 2000; 51(3):127-36. PubMed ID: 11247395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.
    Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma.
    Ikeda Y; Mori M; Haraguchi Y; Sasaki O; Sugimachi K
    Surg Oncol; 1995; 4(5):255-60. PubMed ID: 8850027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
    Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
    Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and coexistence of chromogranin A-, serotonin- and pancreastatin-like immunoreactivity in endocrine-like cells of the human anal canal.
    Hörsch D; Weihe E; Müller S; Hancke E
    Cell Tissue Res; 1992 Apr; 268(1):109-16. PubMed ID: 1499046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
    Pilichowska M; Kimura N; Schindler M; Kobari M
    Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine cells in extrahepatic bile duct carcinoma.
    Yamamoto M; Takahashi I; Iwamoto T; Mandai K; Tahara E
    J Cancer Res Clin Oncol; 1984; 108(3):331-5. PubMed ID: 6150939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.
    Deftos LJ
    Endocr Rev; 1991 May; 12(2):181-7. PubMed ID: 2070778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.